Results 171 to 180 of about 36,802 (283)

Ambient‐Synthesized Tin‐Based Single and Double Perovskite Additives for High‐Efficiency and Long‐Term‐Stable Dye‐Sensitized Solar Cells

Advanced Energy and Sustainability Research, Volume 7, Issue 9, September 2026.
Incorporating ambient‐synthesized, novel tin‐based perovskites as multifunctional liquid electrolyte additives substantially enhances dye‐sensitized solar cell performance. This strategy significantly reduces interfacial resistance and boosts ionic conductivity.
Rachel Anne E. Lagunay, Ayagoz Ibrayeva, Zulfiya Imanbekova, Annie Ng, Bakhytzhan Baptayev, Mannix P. Balanay   +5 more
wiley   +1 more source

Early Radiological Intervention in Budd-Chiari Syndrome: Clinical Outcomes From a Single-Center Study. [PDF]

Int J Hepatol
Ermongkonchai T, Bastas A, Tan K, Testro A.   +3 more
europepmc   +1 more source

Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome

American Journal of Hematology, Volume 101, Issue 9, Page 2147-2156, September 2026.
ABSTRACT Acquired von Willebrand Syndrome (AVWS) is a rare bleeding disorder characterized by quantitative or qualitative defects of von Willebrand factor (VWF) in patients without a personal or family history of bleeding. It is frequently associated with systemic diseases, particularly lymphoproliferative disorders (LPDs) and myeloproliferative ...
Alessandro Ciavarella, Luciano Baronciani, Omid Seidizadeh, Paola Colpani, Elio Ingenito, Daniele Cattaneo, Maria Teresa Pagliari, Addolorata Truma, Alessandra Iurlo, Simona Maria Siboni, Flora Peyvandi   +10 more
wiley   +1 more source

Mutational landscape of classical myeloproliferative neoplasms in the Western Cape Province, South Africa. [PDF]

Afr J Lab Med
Dicks MJ, Nell EM, Swanepoel C, Abdullah I, Chapanduka ZC.   +4 more
europepmc   +1 more source

Calculation of MPN and the Development of a Computer Program for MPN Enumeration

Japanese Journal of Food Microbiology, 2017
openaire   +2 more sources

Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk‐Stratification and Management

American Journal of Hematology, Volume 101, Issue 9, Page 2393-2411, September 2026.
ABSTRACT Disease Overview The myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid disorders characterized by peripheral blood cytopenias and increased risk of transformation to acute myelogenous leukemia (AML). MDS occurs more frequently in older males and in individuals with prior exposure to cytotoxic therapy.
Guillermo Garcia‐Manero
wiley   +1 more source

Efficacy and Safety of Ropeginterferon Alfa-2b in Pregnant Women With Myeloproliferative Neoplasms: Case Series of Three Subtypes and Review. [PDF]

J Korean Med Sci
Kim H, Lee SE, Do YR, Kim SY, Hong J.
europepmc   +1 more source

Genomic Evolution of Myeloproliferative Neoplasms and Therapy-Associated Mutagenesis. [PDF]

Cancer Discov
Leongamornlert D, Lee J, Kamizela AE, To K, Myers D, Williams N, Nyamondo K, Wang X, Guo J, Dissanayake RK, Price J, Durrani AJ, Lambert J, Spencer Chapman M, Pimanda JE, Baxter EJ, Green AR, Godfrey AL, Nangalia J.   +18 more
europepmc   +1 more source

Pre‐Coordination Engineering Enables Synergistic Fe‐Based Single Atoms and Atomic Clusters for High‐Performance Zinc‐Air Batteries

cMat, Volume 3, Issue 3, September 2026.
ABSTRACT Integrating single atoms and atomic clusters presents a promising strategy to enhance electrocatalytic performance. Herein, a bifunctional oxygen electrocatalyst featuring Fe atomic clusters and single atoms in nitrogen‐doped carbon nanotubes (FeAC/FeSA‐N‐CNTs) was fabricated via a pre‐coordination strategy.
Yifei Liu, Ying Yu, Jingyun Cao, Porun Liu, Lei Wang, Lingbo Zong   +5 more
wiley   +1 more source

Ruxolitinib Pharmacokinetics and Exposure–Toxicity Relationship in Hematologic Malignancies and Immune‐Mediated Diseases: A Prospective Observational Study

Clinical Pharmacology &Therapeutics, Volume 120, Issue 3, Page 753-761, September 2026.
Ruxolitinib pharmacokinetics (PK) has been characterized in clinical trials but remains poorly documented in real‐world practice. This project aimed to investigate ruxolitinib PK in routine clinical practice, identify factors driving its variability, and explore exposure–response relationships to assess the potential role of therapeutic drug monitoring.
Jérémie Tachet, Sara C. Meyer, Francesco Grandoni, Emmanuel Haefliger, Monika Nagy‐Hulliger, Jörg P. Halter, Jakob R. Passweg, David Haefliger, Carine Bardinet, Laurent A. Decosterd, Monia Guidi, François R. Girardin   +11 more
wiley   +1 more source